The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout
Abstract
PURPOSE (1) To compare the efficacy of continued and stopping treatment for 0.05%, 0.025% and 0.01% atropine during the third year. (2) To evaluate the efficacy of continued treatment over 3 years. (3) To investigate the rebound phenomenon and its determinants after cessation of treatment. DESIGN A randomized, double-masked extended trial PARTICIPANTS: 350 of 438 children aged 4-12 years originally recruited into the Low-Concentration Atropine for Myopia Progression (LAMP) study METHODS: At the beginning of the third year, children in each group were randomized at a 1:1 ratio to a continued treatment and washout subgroup. Cycloplegic spherical equivalent (SE) refraction and axial length (AL) were measured at 4-month intervals. MAIN OUTCOMES MEASURES Changes in SE and AL between groups RESULTS: 326 children completed 3 years of follow-up. During the third year, SE progression and AL elongation were faster in the washout subgroups than in the continued treatment groups across all concentrations (-0.68±0.49D vs.-0.28±0.42D (P<0.001) and 0.33±0.17mm vs. 0.17±0.14mm (P<0.001) for the 0.05%; -0.57±0.38D vs. -0.35±0.37D (P=0.004) and 0.29±0.14mm vs. 0.20±0.15mm (P=0.04) for the 0.025%; -0.56±0.40D vs.-0.38±0.49D (P=0.04) and 0.29±0.15mm vs 0.24±0.18mm (P=0.13) for the 0.01%). Over the 3-year period, SE progressions were -0.73±1.04D, -1.31±0.92D, and -1.60±1.32D (P=0.001) for the 0.05%, 0.025%, and 0.01% groups in the continued treatment subgroups, -1.15±1.13D, -1.47±0.77D, and -1.81±1.10D (P=0.03) in the washout subgroup. The respective AL elongation were 0.50±0.40mm, 0.74±0.41mm, and 0.89±0.53mm(P<0.001) for the continued treatment subgroups, and 0.70±0.47mm, 0.82±0.37 mm, and 0.98±0.48mm(P=0.04) for the washout subgroup. The rebound SE progressions during washout were concentration dependent but their differences were clinically small (P=0.15). Older age and lower concentration were associated with smaller rebound effects in both SE progression (P<0.001) and AL elongation (P<0.001). CONCLUSIONS During the third year, continued atropine treatment achieved a better effect across all concentrations compared to the washout regimen. 0.05% atropine remained the optimal concentration over 3 years in Chinese children. The difference in rebound effects were clinically small across all three studied atropine concentrations. Stopping treatment at an older age and lower concentration is associated with a smaller rebound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0442-1 · Cited by 2,747
Statistical Analysis of Correlated Data Using Generalized Estimating Equations: An Orientation
Hanley, J. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf215 · Cited by 2,185
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Metadata
- Authors
- Yam, J. C., Zhang, X. J., Zhang, Y., Wang, Y. M., Tang, S. M., Li, F. F., Kam, K. W., Ko, S. T., Yip, B. H. K., Young, A. L., Tham, C. C., Chen, L. J., & Pang, C. P.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 129
- Issue
- 3
- Pages
- 308-321
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W3206179811
- Cited by
- 222
- References
- 3
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. https://app.cochat.ai/papers/10.1016/j.ophtha.2021.10.002
- The paper
- Yam, J. C., Zhang, X. J., Zhang, Y., Wang, Y. M., Tang, S. M., Li, F. F., Kam, K. W., Ko, S. T., Yip, B. H. K., Young, A. L., Tham, C. C., Chen, L. J., & Pang, C. P. (2022). Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. Ophthalmology. https://doi.org/10.1016/j.ophtha.2021.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.